BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2025.
World J Gastrointest Surg. Apr 27, 2025; 17(4): 104712
Published online Apr 27, 2025. doi: 10.4240/wjgs.v17.i4.104712
Table 2 Antimicrobial resistance profiles of the two major strains of bacteria, n (%)
Antimicrobial resistancePathogenic bacterial species
E. coli (n = 26)
P. aeruginosa (n = 16)
Combine (n = 11)
Others (n = 12)
Amikacin1 (3.70)0 (0.00)0 (0.00)0 (0.00)
Amoxicillin/clavulanic
acid potassium
8 (30.77)6 (37.50)3 (27.27)4 (33.33)
Aztreonam4 (15.38)0 (0.00)0 (0.00)1 (8.33)
Gentamicin4 (15.38)4 (25.00)3 (27.27)3 (25.00)
Ceftazidime0 (0.00)0 (0.00)0 (0.00)1 (8.33)
Cefuroxime12 (46.15)6 (37.50)4 (36.36)6 (50.00)
Cefazolin15 (57.69)9 (56.25)5 (45.45)9 (75.00)
SMZ-TMP11 (42.31)8 (50.00)5 (45.45)6 (50.00)
Piperacillin tazobactam0 (0.00)0 (0.00)0 (0.00)0 (0.00)
Meropenem0 (0.00)0 (0.00)0 (0.00)0 (0.00)
Imipenem0 (0.00)0 (0.00)0 (0.00)0 (0.00)
Levofloxacin3 (11.54)2 (12.50)2 (18.18)0 (0.00)


Write to the Help Desk